FDA Approved: * July 15, 2016 Pharm Company: *ANI PHARMS INC Category:Cancer
Nilutamide, sold under the brand names Nilandron and Anandron, is a nonsteroidal antiandrogen (NSAA) which is used in the treatment of prostate cancer. It has also been studied as a component of feminizing hormone therapy for transgender women and to treat acne and seborrhea in women. It is taken by...
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion